Calpol 6+ Suspension Sugar Free In Bottles - P To GSL - Anomalous, Unnecessary And Unsafe, Says National Pharmacy Association, UK The NPA believes that the reclassification of the bottle presentation of Calpol Six Plus from P to GSL could compromise patient safety, is anomalous in relation to other paracetamol products and is unnecessary as the product can be obtained in alternative packaging that carries less risk. Changes to the
Prescription Only
Medicines Order in 1998 were made to reduce the pack sizes of paracetamol available for sale to the public to prevent both accidental and intentional poisoning.
Source: www.medicalnewstoday.comEonC, The First Extended-Life Primary Cell Neurostimulator For The Treatment Of Chronic Pain Approved In USA And Europe St. Jude Medical, Inc. (NYSE:STJ) announced U.S. Food and Drug Administration (FDA) and European CE Mark approvals of EonC™, the first extended-life primary cell (non-rechargeable) neurostimulator for the treatment of chronic pain. The EonC neurostimulator provides a convenient option for chronic pain patients who prefer or require the simplicity of a non-rechargeable medical device.
Source: www.medicalnewstoday.comInternational Association For The Study Of Pain 12th World Congress - Race Against Pain Launch The Web-community Race Against Pain will be internationally launched by site sponsor Boston Scientific at the International Association for the Study of Pain (IASP) 12th World Congress this month at the Scottish Exhibition & Conference Centre in Glasgow. The Race Against Pain lead spokesman, US racing driver and chronic pain sufferer, Michael Roman (40) will also be in attendance at IASP, acting as an ambassador for the programme and assisting the Congress.
Source: www.medicalnewstoday.com
# posted by Network @ 1:00 PM
